Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Peter Stein Takes Short Path To Director Of US FDA Drug Office

10 Dec 2018

• By Derrick Gingery

FDA entrance sign 2016

Related Content

Gottlieb: The Next Janet Woodcock Is Waiting To Be Discovered At FDA

09 Nov 2017

New CDER No. 2 May Impact FDA's Safety Monitoring Aspirations

18 Apr 2018

Office Of New Drugs Reorg Is Bigger Than Expected: US FDA Adds 11 Review Divisions

04 Jun 2018

Four Rules For Being A Consistent US FDA Reviewer From Peter Stein

10 Dec 2018

US FDA Office Of New Drugs Likely To Be Headed By Deputy Director Stein

21 Nov 2018

CDER Recruitment Wins Begin Outnumbering Losses

27 Nov 2018

'Brilliant' and 'Steady' Jenkins Retiring From US FDA's Office of New Drugs

05 Dec 2016

Merck R&D Exec Jumps To US FDA As Office Of New Drugs Deputy Director

09 Nov 2016

Related Companies

Merck & Co., Inc.

Johnson & Johnson

Pfizer Inc.

Additional Topics

United States FDA Drug Review Leadership Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.